Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
scPharmaceuticals Inc. (SCPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update"
05/10/2023 8-K Quarterly results
Docs: "scPharmaceuticals Inc. Reports First Quarter 2023 Financial Results and Provides Business Update"
03/22/2023 8-K Quarterly results
Docs: "scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update"
11/09/2022 8-K Quarterly results
08/09/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
03/22/2022 8-K Quarterly results
Docs: "scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update"
11/09/2021 8-K Quarterly results
Docs: "scPharmaceuticals Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update"
05/12/2021 8-K Quarterly results
03/23/2021 8-K Quarterly results
11/16/2020 8-K Quarterly results
Docs: "SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : November 16, 2020 SCPHARMACEUTICALS INC. Delaware 001-38293 46-5184075 2400 District Avenue, Suite 310 Burlington, Massachusetts 01803 Registrant's telephone number, including area code: 517-0730",
"scPharmaceuticals Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update"
08/13/2020 8-K Quarterly results
05/12/2020 8-K Quarterly results
Docs: "SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : May 12, 2020 SCPHARMACEUTICALS INC. Delaware 001-38293 46-5184075 2400 District Avenue, Suite 310 Burlington, Massachusetts 01803 Registrant's telephone number, including area code: 517-0730",
"scPharmaceuticals Inc. Reports First Quarter 2020 Financial Results and Provides Business Update"
03/24/2020 8-K Quarterly results
11/12/2019 8-K Quarterly results
08/07/2019 8-K Quarterly results
05/08/2019 8-K Quarterly results
Docs: "Burlington, Massachusetts",
"scPharmaceuticals Inc. Reports First Quarter 2019 Financial Results and Provides Business Update"
03/21/2019 8-K Quarterly results
Docs: "FORM 8-K",
"scPharmaceuticals Inc. Reports Fourth Quarter and Year Ended 2018 Financial Results and Provides Business Update"
11/13/2018 8-K Quarterly results
Docs: "SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : November 13, 2018 SCPHARMACEUTICALS INC. Delaware 001-38293 46-5184075 2400 District Avenue, Suite 310 Burlington, Massachusetts 01803 Registrant's telephone number, including area code: 517-0730",
"scPharmaceuticals Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update"
08/14/2018 8-K Quarterly results
Docs: "scPharmaceuticals Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update"
05/07/2018 8-K Quarterly results
Docs: "SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : May 7, 2018 SCPHARMACEUTICALS INC. Delaware",
"scPharmaceuticals Inc. Reports First Quarter 2018 Financial Results and Provides Business Update"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy